Historical record - last NADAC effective date: 2/17/2021

Product Information

FENOFIBRATE 160 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2373 per EA under NDC 62332053991. Its NADAC has been published 48 times since Apr 1, 2020.

FDA first approved this application on Feb 11, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FENOFIBRATE 160 MG TABLET

Fenofibrate
$0.2373per EA

Strength

160 mg/1

NDC

62332053991

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/17/2021

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209660

FDA Approved

2/11/2019

TE Code

AB

On Market Since

2/12/2019

Price Statistics

The NADAC for FENOFIBRATE 160 MG TABLET has been published 48 times since Apr 1, 2020, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2373 per EA
All-time high$0.3230 (Jul 15, 2020)
All-time low$0.1919 (Sep 23, 2020)
Median price$0.2454
Average price$0.2506
Largest weekly change-26.9% (Jul 22, 2020)
Weeks tracked48
Tracking sinceApr 1, 2020

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-15.0%

Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FENOFIBRATE 160 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.2373 per EA (NDC 62332053991), effective Feb 24, 2021.

How has the price of FENOFIBRATE 160 MG TABLET changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 15.0%. It has been tracked across 48 weekly CMS publications since Apr 1, 2020.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?

Since Apr 1, 2020, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.1919 (Sep 23, 2020) to a high of $0.3230 (Jul 15, 2020), with a median of $0.2454 per EA.

Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 160 MG TABLET, is $0.1008 per EA — about 58% below FENOFIBRATE 160 MG TABLET.

Who manufactures FENOFIBRATE 160 MG TABLET?

FENOFIBRATE 160 MG TABLET (NDC 62332053991) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.